<DOC>
	<DOCNO>NCT02948881</DOCNO>
	<brief_summary>The purpose study estimate effect oral Boniva ( ibandronate sodium ) take monthly versus placebo bone quality strength hip one year .</brief_summary>
	<brief_title>A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Inclusion criterion : Ambulatory , postmenopausal woman diagnose osteoporosis . Must able stand sit upright least 60 minute swallow tablet whole . Exclusion criterion : Have treat bisphosphonates use chronic steroid within past 6 month . Have history major upper GI disease severe kidney dysfunction . Have spine fracture ( identified xray ) .</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>bisphosphonates</keyword>
	<keyword>bone</keyword>
</DOC>